Boyer, Blaye et al. show that CD52-expressing immunosuppressive myeloid cells can shape breast tumor plasticity beyond immune evasion. They show that this myeloid subset delivers membrane-bound TGF-β1 via cell contact to generate mesenchymal-like cancer stem cells in luminal breast cancer, and TGF-β blockade prevents this stemness program.